June 13, 2019
June 13, 2019 —
…San Diego School of Medicine receives big investment for RNA therapeutics Local biotech company Locana made news last month when it raised $55 million in venture capital funding. Locana means “illuminate” or “vision” in Sanskrit, and the company is based on technology that was originally developed to illuminate RNA inside…
March 13, 2013
March 13, 2013 —
Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine have used a newly discovered function of an old drug to restore cell communications in a mouse model of autism, reversing symptoms of the devastating disorder.
March 20, 2014
March 20, 2014 —
…security, psychopathology, job screening, medicine, and law, said Bartlett. “As with causes of pain, these scenarios also generate strong emotions, along with attempts to minimize, mask, and fake such emotions, which may involve ‘dual control’ of the face,” she said. “In addition, our computer-vision system can be applied to detect…
August 15, 2013
August 15, 2013 —
Research led by scientists from the University of California, San Diego has decoded the genetic basis of chronic mountain sickness (CMS) or Monge’s disease. Their study provides important information that validates the genetic basis of adaptation to high altitudes, and provides potential targets for CMS treatment.
April 2, 2018
April 2, 2018 —
Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the bill. Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego estimate that illness and death resulting from non-optimized medication therapy costs $528.4…
December 19, 2023
December 19, 2023 —
Albert Lin ‘05, ‘06, ‘08 speaks about his new TV show, his roots at UC San Diego, and why he keeps going despite the hazards of life on the road.
December 18, 2018
December 18, 2018 —
After living with debilitating phantom leg pain for 18 years, Raul Silva is excited about a new dorsal root ganglion (DRG) stimulation device that erased his pain during a testing phase at UC San Diego Health, one of the only health care providers in the region offering the device.